NIH-funded research U01 cooperative agreement

Using telehealth to detect and manage glaucoma in high-risk groups

Official title: DP24-081 Novel telehealth technologies to detect and manage glaucoma and vision-threatening eye diseases in high-risk populations

Funded at University of California, San Francisco · NIH-11030179 · Data updated 2026-11-12

This study is looking at how well telemedicine can help find glaucoma and other eye problems early in Black and Latino communities that may not have easy access to eye care, and it’s inviting people to take part in this important research.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 30, 2024
Project endSeptember 29, 2029
Funding year2024
Award (this year)$695,692
NIH project number1U01DP006820-01
Project IDNIH-11030179 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals from high-risk groups, particularly Black and Latino populations, who may be undiagnosed with glaucoma.

Less likely to help

Patients who do not belong to high-risk groups or those who already have diagnosed glaucoma may not benefit from this research.

What this research studies

This research investigates the use of telemedicine to screen for glaucoma in populations at high risk, such as Black and Latino individuals. It aims to determine how effective this approach is in detecting glaucoma early, as well as identifying other eye conditions like cataracts or refractive errors. The study will take place at Federally Qualified Health Centers in northern California, where access to eye care is limited. Participants will be randomly assigned to receive telemedicine screening, educational materials, or a delayed intervention.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and management of glaucoma, potentially preventing vision loss in high-risk populations.

How similar studies have gone: Previous research has shown that telemedicine can be effective in screening for various health conditions, suggesting potential success for this novel approach in glaucoma detection.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Keenan, Jeremy David — University of California, San Francisco
  • Study coordinator: Keenan, Jeremy David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.